B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia.

Academic Article

Abstract

  • Waldenstr├Âm macroglobulinemia (WM) is a serious and frequently fatal B-cell malignancy associated with an elevated monoclonal IgM protein in the serum. Many of the mechanisms leading to this disease are not yet known. B-lymphocyte stimulator (BLyS) is a TNF family member that is critical for maintenance of normal B-cell development and homeostasis. BLyS is overexpressed in a variety of B-cell malignancies and has been shown to inhibit apoptosis in malignant B cells. It also regulates immunoglobulin secretion by normal B cells. To determine the relevance of BLyS in WM, we examined the role of BLyS in WM patient samples. Malignant B cells were found to bind soluble BLyS and variably express the receptors BAFF-R, TACI, and BCMA. We also found expression of BLyS in bone marrow specimens by immunohistochemistry and elevated serum BLyS levels in patients with WM. BLyS, alone or in combination with cytokines that induce immunoglobulin production, was found to increase IgM secretion by malignant B cells. Furthermore, BLyS was found to increase the viability and proliferation of malignant B cells from WM patients. Due to the role of BLyS in WM, strategies to inhibit BLyS may potentially have therapeutic efficacy in these patients.
  • Authors

  • Elsawa, Sherine
  • Novak, Anne J
  • Grote, Deanna M
  • Ziesmer, Steven C
  • Witzig, Thomas E
  • Kyle, Robert A
  • Dillon, Stacey R
  • Harder, Brandon
  • Gross, Jane A
  • Ansell, Stephen M
  • Status

    Publication Date

  • April 1, 2006
  • Published In

  • Blood  Journal
  • Keywords

  • B-Cell Activating Factor
  • B-Lymphocytes
  • Cell Division
  • Cell Line
  • Flow Cytometry
  • Humans
  • Immunoglobulins
  • Membrane Proteins
  • Neoplasms
  • Tumor Necrosis Factor-alpha
  • Waldenstrom Macroglobulinemia
  • Digital Object Identifier (doi)

    Start Page

  • 2882
  • End Page

  • 2888
  • Volume

  • 107
  • Issue

  • 7